BTIG Reiterates Buy Rating on Abbott Labs (ABT)

December 22, 2025 8:41 AM EST Send to a Friend
BTIG analyst Marie Thibault reiterated a Buy rating and $145.00 price target on Abbott Labs (NYSE: ABT).The analyst commented: "This ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login